Bupron Xl 300 mg Sun Pharmaceuticals Industries

£37.00

Bupron XL 300 mg is a sustained-release bupropion formulation from Sun Pharmaceuticals for in-vitro neurochemical research applications.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Bupron Xl 300 mg Sun Pharmaceuticals Industries
Bupron Xl 300 mg Sun Pharmaceuticals Industries
£37.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Overview of Bupron XL 300mg Research Compound

Bupron XL 300 mg is a sustained-release bupropion hydrochloride formulation manufactured by Sun Pharmaceuticals Industries for laboratory research applications. This extended-release preparation provides researchers with a controlled delivery mechanism for investigating norepinephrine and dopamine reuptake inhibition in cellular and tissue models. The compound serves as a valuable reference standard for neurochemical research protocols examining aminoketone antidepressant mechanisms.

Research Applications in Laboratory Settings

Researchers utilize Bupron XL 300 mg to study dopaminergic and noradrenergic neurotransmitter systems in controlled laboratory environments. The sustained-release formulation allows investigation of prolonged neurotransmitter reuptake inhibition effects in cell culture models. Studies examining the compound’s unique mechanism distinguish it from selective serotonin reuptake inhibitors, making it particularly valuable for comparative neuropharmacology research. The 300 mg strength provides sufficient material for multiple experimental protocols. Investigators at Stroid UK Shop can access this pharmaceutical-grade compound for specialized neurochemical studies.

Research teams studying smoking cessation mechanisms frequently employ bupropion compounds to examine nicotinic acetylcholine receptor antagonism pathways. The extended-release formulation enables researchers to model sustained pharmacokinetic profiles in laboratory settings. Scientists investigating seasonal affective disorder models utilize this compound to study its unique dual neurotransmitter activity. Comparative studies with compounds available in our bupropion research category enhance understanding of aminoketone pharmacology. Additionally, researchers exploring metabolic pathways often examine this compound alongside other research tools from our SARMs collection and peptide research compounds for comprehensive neurometabolic studies.

Specifications and Storage Requirements

Bupron XL 300mg Research Compound Specifications
Parameter Value
Active Compound Bupropion Hydrochloride
Formulation Extended-Release Tablets
Strength 300 mg per tablet
Manufacturer Sun Pharmaceuticals Industries
CAS Number 34841-39-9
Molecular Formula C₁₃H₁₈ClNO·HCl
Storage Temperature Room temperature (20-25°C)
Storage Conditions Dry environment, protect from light

Research Compliance Statement

Bupron XL 300 mg is supplied exclusively for in-vitro laboratory research purposes and analytical applications. This compound is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory protocols and safety measures when handling this material. All studies should comply with institutional research guidelines and applicable regulations governing laboratory research compounds.

Related